CFC inhalers to be phased out by 2003

The European Commission has adopted a strategy, as required under the Montreal Protocol, for phasing out the use of CFCs in metered dose inhalers (MDIs). CFCs are still available for use in MDIs under the Protocol's "essential uses" exemption. Worldwide, 500 million MDIs are used each year, of which 200 million are made in Europe, using 6,635 tonnes of CFCs.

Sorry you do not have access to this article. Please contact Customer Support at
report@ends.co.uk
or call 020 8267 8120